The estimated Net Worth of Harry Kovelman is at least $668 millier dollars as of 5 September 2024. Dr Kovelman owns over 6,700 units of Myomo Inc stock worth over $504,108 and over the last 3 years he sold MYO stock worth over $164,050.
Sign up
Dr D MYO stock SEC Form 4 insiders trading
Dr has made over 5 trades of the Myomo Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he sold 6,700 units of MYO stock worth $25,192 on 5 September 2024.
The largest trade he's ever made was selling 35,426 units of Myomo Inc stock on 15 May 2024 worth over $130,722. On average, Dr trades about 1,241 units every 8 days since 2021. As of 5 September 2024 he still owns at least 123,556 units of Myomo Inc stock.
You can see the complete history of Dr Kovelman stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Harry Kovelman M.D. biography
Dr. Harry Kovelman M.D. is the Chief Medical Officer at Myomo Inc.
How old is Dr D?
Dr D is 62, he's been the Chief Medical Officer of Myomo Inc since . There are 2 older and 5 younger executives at Myomo Inc. The oldest executive at Myomo Inc is Clifford J. Conneighton, 71, who is the Chief Marketing Officer.
What's Dr D's mailing address?
Harry's mailing address filed with the SEC is C/O MYOMO, INC., 137 PORTLAND ST., 4TH FLOOR, BOSTON, MA, 02114.
Insiders trading at Myomo Inc
Over the last 7 years, insiders at Myomo Inc have traded over $203,224 worth of Myomo Inc stock and bought 776,898 units worth $937,925 . The most active insiders traders include Steve Sanghi, Paul R Gudonis et Heather C Getz. On average, Myomo Inc executives and independent directors trade stock every 57 days with the average trade being worth of $120,686. The most recent stock trade was executed by Harry Kovelman on 5 September 2024, trading 6,700 units of MYO stock currently worth $25,192.
What does Myomo Inc do?
myomo's mission is to enable individuals to overcome their paralysis by providing innovative, myoelectric orthotics and support services. we are committed to working with healthcare professionals to deliver high quality outcomes and patient satisfaction through research collaborations and continuing education programs. the company empowers persons with a neuromuscular disability to perform functional activities at home, at work, and in the community, resulting in an improved quality of life and lower healthcare costs.
What does Myomo Inc's logo look like?
Complete history of Dr Kovelman stock trades at Myomo Inc
Myomo Inc executives and stock owners
Myomo Inc executives and other stock owners filed with the SEC include:
-
Paul R. Gudonis,
Chairman, Pres & CEO -
David A. Henry,
Chief Financial Officer -
Micah J. Mitchell,
Chief Commercial Officer -
Jonathan Naft,
VP & GM -
Fredrick Nahm,
Medical Director -
Jonathan Naft,
General Manager - O&P -
David Henry,
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer -
Paul Gudonis,
Chief Executive Officer, Director -
Steve Kelly,
Founder, Chairman of the Board, President and Chief Operating Officer -
Dr. Harry Kovelman M.D.,
Chief Medical Officer -
Clifford J. Conneighton,
Chief Marketing Officer -
Thomas F Kirk,
-
Ralph A Goldwasser,
Chief Financial Officer -
Steve Sanghi,
Director -
Cliff Conneighton,
Chief Marketing Officer -
Micah Mitchell,
Chief Commercial Officer -
Davie Mendelsohn,
VP, Sales -
Brandon M Green,
Chief Medical Officer -
Thomas Aloysius Jr. Crowley,
-
Milton Mayo Morris,
-
Harry Kovelman,
Chief Medical Officer -
Amy K. Knapp,
-
Heather C Getz,